D2R : DNA to RNA

D2R : DNA to RNA D2R | DNA to RNA is a research initiative at McGill University taking an inclusive Canadian approach to genomic-based RNA therapeutics.

🌟 Now Hiring: Associate Director, Indigenous Health Research for DNA to RNA (D2R) 🌟D2R is seeking a strategic and collab...
03/20/2026

🌟 Now Hiring: Associate Director, Indigenous Health Research for DNA to RNA (D2R) 🌟

D2R is seeking a strategic and collaborative leader to join our team as Associate Director, Indigenous Health Research.

🧬 About the Role
Reporting to the Director of Administration, the Associate Director will lead the development and implementation of D2R’s Indigenous Strategy and Research Plan. This role supports Indigenous-led health research, fosters strong partnerships with Indigenous communities and organizations, and ensures the integration of Indigenous knowledge across all aspects of research and training.

đź’Ľ Key Responsibilities
Lead the development and ex*****on of D2R’s Indigenous Strategy and Research Plan.
Build and maintain meaningful partnerships with Indigenous communities and organizations.
Support and advance Indigenous-led health research initiatives.
Oversee funding opportunities, training programs, and community engagement activities.
Manage and support a team dedicated to Indigenous research and partnerships.

đź”— Apply now: https://mcgill.wd3.myworkdayjobs.com/en-US/McGill_Careers/job/Associate-Director-Indigenous-Health-Research_JR0000074649-1

---

🌟 Nous recrutons : Directeur(trice) associé(e), recherche en santé autochtone pour DNA to RNA (D2R) 🌟
D2R est à la recherche d’un leader stratégique et collaboratif pour occuper le poste de Directeur(trice) associé(e), recherche en santé autochtone.

🧬 À propos du poste
Relevant du Directeur de l’administration, le(la) Directeur(trice) associé(e) dirigera l’élaboration et la mise en œuvre de la stratégie et du plan de recherche en santé autochtone de D2R. Ce rôle soutient la recherche en santé dirigée par des Autochtones, favorise des partenariats solides avec les communautés et organisations autochtones, et veille à l’intégration des savoirs autochtones dans l’ensemble des activités de recherche et de formation.

💼 Responsabilités principales
Diriger l’élaboration et la mise en œuvre de la stratégie et du plan de recherche en santé autochtone de D2R.
Établir et entretenir des partenariats significatifs avec les communautés et organisations autochtones.
Soutenir et faire progresser les initiatives de recherche en santé dirigées par des Autochtones.
Superviser les occasions de financement, les programmes de formation et les activités d’engagement communautaire.
Gérer et soutenir une équipe dédiée à la recherche et aux partenariats autochtones.

🔗 Postulez dès maintenant : https://mcgill.wd3.myworkdayjobs.com/fr-CA/McGill_Careers/job/Associate-Director-Indigenous-Health-Research_JR0000074649-1

For International Day of Persons with Disabilities, join Dr. Grant Bruno at McGill University for a talk on decolonizing...
11/27/2025

For International Day of Persons with Disabilities, join Dr. Grant Bruno at McGill University for a talk on decolonizing our understanding of neurodiversity.

On December 3rd, discover how Indigenous knowledge and perspectives can serve as a vital source of support for Indigenous families with autistic children.

The day includes:

Film Screening: They Are Sacred, 12:00–2:30 PM at the First Peoples House

Reception & Keynote Address: 5:00–8:00 PM, Armstrong 365

Register now: https://www.mcgill.ca/equity/category/tags/accessibility-mcgill/international-day-persons-disabilities/idpd-2025

Newly appointed Chief Scientific Officer (CSO) of D2R, Philippe Gros, shares his vision for the future in a letter to th...
11/05/2024

Newly appointed Chief Scientific Officer (CSO) of D2R, Philippe Gros, shares his vision for the future in a letter to the D2R community.

"As we move forward, our mission is clear: to develop next-generation RNA therapies that are accessible, equitable, and inclusive," said Gros. "Together, we have the potential to deliver groundbreaking RNA therapies that can change lives and shape the future of healthcare."

Read the letter: https://buff.ly/3AiGytJ



***

Philippe Gros, récemment nommé directeur scientifique en chef de l'initiative D2R, partage sa vision de l'avenir dans une lettre adressée à la communauté de D2R.

« Notre mission pour l’avenir est claire : mettre au point des thérapies de type ARN de prochaine génération qui sont accessibles, équitables et inclusives », a déclaré Philippe Gros. « Ensemble, nous pouvons offrir des thérapies de type ARN novatrices qui peuvent changer des vies et façonner l’avenir des soins de santé. »

Lire la lettre : https://buff.ly/3AvXJbd

Dear D2R Community, I am deeply honored to step into the role of Chief Scientific Officer for the DNA to RNA (D2R) Initiative, and I want to take this opportunity to share my vision for the future as we embark on this exciting journey together. The rapid development of RNA technologies, illustrated....

🎉 D2R is proud to welcome three newly appointed researchers at Université de Sherbrooke, the first to receive funding th...
10/31/2024

🎉 D2R is proud to welcome three newly appointed researchers at Université de Sherbrooke, the first to receive funding through our New Faculty Start-Up program. 🤝

This program strengthens our collaborative efforts to advance breakthrough discoveries in microbiology, biochemistry, and immunology. With support from D2R, these researchers will lead innovative projects that align with our mission of developing transformative RNA-based therapies for diverse health challenges.

Learn more about their impactful research: https://buff.ly/4f4NwRZ

Faculté de médecine et des sciences de la santé

We are excited to announce the appointment of Philippe Gros as Chief Scientific Officer (CSO) of McGill’s DNA2RNA initia...
10/31/2024

We are excited to announce the appointment of Philippe Gros as Chief Scientific Officer (CSO) of McGill’s DNA2RNA initiative. An internationally recognized researcher and former Deputy Vice-President (Research and Innovation) at McGill, Philippe brings decades of expertise in genomics and RNA therapies to this new role. He is widely known for his discoveries of genes, proteins, and pathways that influence complex human diseases.

Gros played a key role in laying the foundation for D2R's success and will now lead efforts to accelerate groundbreaking advancements in RNA-based precision medicine. With over 400 scientific publications, six patents, and prestigious awards like the McLaughlin Medal for Scientific Excellence and the Killam Prize in Health Sciences, his leadership will be instrumental in driving our mission forward.

"The work being done within D2R holds the promise to revolutionize treatment options for a wide range of diseases, and in different Canadian populations, and I look forward to collaborating with our team to accelerate this vital work,” said Gros.

Join us in welcoming Philippe Gros as the Chief Scientific Officer of D2R.

Read more about his appointment here: https://buff.ly/48rk1Yf

🔊  : "B-cell derived extracellular vesicles with enriched miRNA contents that mitigate Th2 inflammation" led by Bruce Ma...
10/24/2024

🔊 : "B-cell derived extracellular vesicles with enriched miRNA contents that mitigate Th2 inflammation" led by Bruce Mazer, Research Institute of the McGill University Health Centre.

Co-Investigator: Janusz Rak (Research Institute of the McGill University Health Centre)
Collaborator: Yasser Riaz Al-Hosseini (McGill University)

This project aims to develop and test laboratory-produced B-Cell-derived extracellular vesicles (B2-EV) as a potential low-toxicity therapy for severe asthma by targeting multiple genes through miRNA in preclinical mouse models.

đź”— Learn more: https://buff.ly/3Nzempi

🔊  : "McGill Brand mRNA Production" led by Nathan Luedtke, McGill University.Co-Investigators: Masad Damha (McGill Unive...
10/23/2024

🔊 : "McGill Brand mRNA Production" led by Nathan Luedtke, McGill University.

Co-Investigators: Masad Damha (McGill University) and Maureen McKeague (McGill University)

This project includes mRNA production technologies and student training aimed at establishing a Quebec-based production platform.

đź”— Learn more: https://buff.ly/48jGwOs

🔊  : "A first inclusive study on the ELSI aspects of RNA technologies and therapeutics" led by Yann Joly, McGill Univers...
10/22/2024

🔊 : "A first inclusive study on the ELSI aspects of RNA technologies and therapeutics" led by Yann Joly, McGill University.

Collaborators: Thomas Duchaine (McGill University), Silvia Vidal (McGill University) and Charles Dupras (Université de Montréal)

This project will be the first to identify ethical, legal, and social issues raised by research and medical practice involving RNA technologies.

đź”— Learn more: https://buff.ly/4eSzXoO

🔊  : "Modelling individual differences in patterns of epigenetic regulation" led by Celia Greenwood, Jewish General Hosp...
10/17/2024

🔊 : "Modelling individual differences in patterns of epigenetic regulation" led by Celia Greenwood, Jewish General Hospital.

Co-Investigators: Josée Dupuis (McGill University) and Qihuang Zhang (McGill University)

This project aims to develop advanced statistical methods to analyze epigenetic data types and identify epigenetic patterns associated with disease.

đź”— Learn more: https://buff.ly/3YqeJJ9

🔊  : "Engineering a Circular RNA Platform for Cap-Dependent Translation" led by Masad Damha, McGill University.Co-Invest...
10/16/2024

🔊 : "Engineering a Circular RNA Platform for Cap-Dependent Translation" led by Masad Damha, McGill University.

Co-Investigator: Sidong Huang (McGill University)

This project explores the effects of diverse chemical modifications on circular RNA translation to synthetically produce molecules tailored for human therapeutics.

đź”— Learn more: https://buff.ly/3Y6cGs7

🔊  : "pHREEDOM: A pH-Responsive probe to study Endosomal Escape for RNA Delivery Optimization and Monitoring" led by Pie...
10/15/2024

🔊 : "pHREEDOM: A pH-Responsive probe to study Endosomal Escape for RNA Delivery Optimization and Monitoring" led by Pieter Cullis, University of British Columbia.

Co-Investigator: Anna Blakney (University of British Columbia)
Collaborator: Sabrina Leslie (University of British Columbia)

This project uses a pH-responsive probe to track the pH inside LNPs in order to optimize the delivery and design of gene therapies and increase treatment efficiency.

đź”— Learn more: https://buff.ly/406v2Mn

Address

1010, Rue Sherbrooke
Montreal, QC
H3A2R7

Alerts

Be the first to know and let us send you an email when D2R : DNA to RNA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share